Avista Capital-backed United BioSource, a biopharmaceutical company providing integrated clinical, safety, and commercialization services, completed the acquisition of Examoto, a risk evaluation and mitigation strategy company. Financial terms were not disclosed. "We are excited by the compelling opportunities this acquisition presents to expand the industry's leading one-stop-shop for full-service REMS programs. The combination of Examoto's technology-driven approach with UBC's scientific, technological, and operational expertise will ensure the most efficient delivery of successful REMS programs to patients and clients," Patrick Lindsay, UBC President and CEO.